Related Experiment Videos
Platelet-derived growth factor and autocrine mechanisms of oncogenic processes
1University of Uppsala, Sweden.
Critical Reviews in Oncogenesis
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.
Journal of internal medicine·2017
TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor.
Biochemical and biophysical research communications·2002
Review Article: Intratumoral Immunotherapy: Old Discoveries and Recent Developments in Sarcomas.
Critical reviews in oncogenesis·2026
Review Article: Dynamin-Related Protein 1 in Cancer Progression: Mechanisms and Implications.
Critical reviews in oncogenesis·2026
Review Article: EZH2 in Pancreatic Cancer: Epigenetic Driver and Therapeutic Target.
Critical reviews in oncogenesis·2026
Review Article: YY2 in Tumor Regulation: Core Mechanisms and Functional Networks.
Critical reviews in oncogenesis·2026
Review Article: Decoding the Role of PBX3 in Cancer: Molecular Mechanisms and Therapeutic Strategies.
Critical reviews in oncogenesis·2026
Research Article: The Dysregulated YY1-Bcl-2-c-Myc Axis in Non-Hodgkin Lymphoma: Validation by Bioinformatic Analyses.
Critical reviews in oncogenesis·2026
Follicular lymphoma and the microenvironment: potential targets and biomarkers.
Expert review of clinical immunology·2026
Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.
Molecular cancer therapeutics·2026
Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.
Cancer reports (Hoboken, N.J.)·2026